Forward Pharma A/S (Forward Pharma A/S) ROCE % : 0.92% (As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Forward Pharma A/S's annualized ROCE % for the quarter that ended in Jun. 2022 was 0.92%.

Forward Pharma A/S ROCE % Historical Data

The historical data trend for Forward Pharma A/S's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S ROCE % Chart

Forward Pharma A/S Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

967.23

-14.29

-6.61

-4.34

-5.18

Forward Pharma A/S Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
ROCE %	Get a 7-Day Free Trial															-5.29	-3.54	-2.68	-7.79	0.92

Forward Pharma A/S ROCE % Calculation

Forward Pharma A/S's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-3.874	/	( ( (79.714 - 1.07)	+	(71.405 - 0.608) )	/ 2 )
	=	-3.874	/	( (78.644	+	70.797)	/ 2 )
	=	-3.874	/	74.7205
	=	-5.18 %

Forward Pharma A/S's ROCE % of for the quarter that ended in Jun. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2022 )		(Q: Dec. 2021 )		(Q: Jun. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2022 )		(Q: Dec. 2021 )		(Q: Jun. 2022 )
	=	0.608	/	( ( (71.405 - 0.608)	+	(65.644 - 3.561) )	/ 2 )
	=	0.608	/	( ( 70.797	+	62.083 )	/ 2 )
	=	0.608	/	66.44
	=	0.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2022) EBIT data.

Forward Pharma A/S (OTCPK:FWPAY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Forward Pharma A/S ROCE % Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100

Website

https://www.forward-pharma.com

Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.